Institute of Molecular and Cell Biology (IMCB)
Min Thura has not added Biography.
If you are Min Thura and would like to personalize this page please email our Author Liaison for assistance.
PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types.
Theranostics , 2023 | Pubmed ID: 37064866
A*STAR 61 Biopolis Drive
Kelvin Kam Yew Kuan*,1,
Ke Zhang*,1,2,
Koon Hwee Ang1,
Min Thura1,
Wei Hui Zheng3,4
1Institute of Molecular and Cell Biology (IMCB), A*STAR 61 Biopolis Drive,
2Department of Radiation Oncology, Affiliated Hangzhou Cancer Hospital,
3Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital,
4, Department of Thyroid Surgery of Zhejiang Cancer Hospital
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
Research
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved
